HR 7347
118th Congress
House
Armed Forces and National Security
Alternative treatments
Congressional oversight
Drug safety, medical device, and laboratory regulation
Drug trafficking and controlled substances
Prescription drugs
To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to report on whether the Secretary will include certain psychedelic drugs in the formulary of the Department of Veterans Affairs.
Introduced: February 14, 2024
Introduced by:
Van Orden, Derrick
Republican
· Wisconsin
See on congress.gov
Everywhere this bill has been
10 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 6, 2024
Placed on the Union Calendar, Calendar No. 544.
Sep 6, 2024
Reported by the Committee on Veterans' Affairs. H. Rept. 118-647.
May 1, 2024
Ordered to be Reported by Voice Vote.
May 1, 2024
Committee Consideration and Mark-up Session Held
Apr 16, 2024
Forwarded by Subcommittee to Full Committee by Voice Vote.
Apr 16, 2024
Subcommittee Consideration and Mark-up Session Held
Mar 21, 2024
Subcommittee Hearings Held
Feb 29, 2024
Referred to the Subcommittee on Health.
Feb 14, 2024
Referred to the House Committee on Veterans' Affairs.
Feb 14, 2024
Introduced in House
Plain-English summary
This bill requires the Department of Veterans Affairs (VA), when a psychedelic drug is approved or licensed by the Food and Drug Administration, to report on the VA's decision whether to include the drug in its formulary and the justification for such decision.
What's happening now
Placed on the Union Calendar, Calendar No. 544.
Committees of jurisdiction
2
Cosponsors
1